INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,431,090 | -49.7% | 45,259 | -35.1% | 0.00% | -60.0% |
Q2 2023 | $2,843,997 | +232.3% | 69,740 | +203.7% | 0.01% | +150.0% |
Q1 2023 | $855,943 | -1.2% | 22,966 | -7.5% | 0.00% | -20.0% |
Q4 2022 | $866,493 | -28.0% | 24,835 | +49.9% | 0.01% | -50.0% |
Q1 2022 | $1,204,000 | +442.3% | 16,572 | +903.1% | 0.01% | +233.3% |
Q3 2021 | $222,000 | -92.6% | 1,652 | -91.1% | 0.00% | -91.2% |
Q2 2021 | $3,009,000 | – | 18,584 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |